Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Go back to Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update| (NASDAQ: VRDN) | Delayed: 16.15 +0.38 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.77 | 52 Week High | $ | |||
| Open | $15.75 | 52 Week Low | $ | |||
| Day High | $16.22 | P/E | N/A | |||
| Day Low | $15.62 | EPS | $ | |||
| Volume | 971,945 | |||||

